(Q53663389)

17 May 2018

title

Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. (English)

1 reference

17 May 2018

author name string

Michael H Albert

1

1 reference

17 May 2018

Yan Liu

2

1 reference

17 May 2018

Claudio Anasetti

3

1 reference

17 May 2018

Xue-Zhong Yu

4

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 September 2005

1 reference

17 May 2018

European Journal of Immunology

published in

1 reference

17 May 2018

volume

35

1 reference

17 May 2018

issue

9

1 reference

17 May 2018

page(s)

2598-2607

1 reference

17 May 2018

Tracking the immunoregulatory mechanisms active during allograft tolerance.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

Haematopoietic cell transplantation as immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Hematopoietic stem cell transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Regulatory T cells in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Forkhead-box transcription factors and their role in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Association of Foxp3 regulatory gene expression with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

CD4+CD25+ T cells as immunoregulatory T cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Advances in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

CD28-specific antibody prevents graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526077

7 January 2021

Identifiers

DOI

10.1002/EJI.200526077

1 reference

17 May 2018

PubMed ID

16078276

1 reference

17 May 2018